Ozempic Reimbursed in Alberta, Canada for Adults Living with Type 2 Diabetes

Novo Nordisk announced that Ozempic (semaglutide injection) will now be publicly reimbursed in the province of Alberta in Canada. “Diabetes …

AstraZeneca’s Brilinta with Aspirin Reduces Heart Related Events in Late Trials

AstraZeneca reported positive phase 3 trial results of Brilinta (ticagrelor) plus aspirin, which reduced the relative risk of cardiovascular events …

Text Messages with Motivational Messages May Help Patients with Diabetes

Motivational text messaging may be the key to improving blood sugar control in patients with diabetes and coronary heart disease, according to a new …

Innovent and Eli Lilly to Develop and Potentially Sell Novel Diabetes Medicine in China

Innovent Biologics, Inc. announced that it has entered into a licensing agreement with Eli Lilly and Company for the development and potential …

Mobile Apps for Insulet’s Omnipod System Now Available for iOS Devices

Insulet Corporation, a developer of tubeless insulin pump technology with its Omnipod System, announced the full market launch of the Omnipod …

Back to School: College Students with Diabetes Face Unique Challenges

It’s back to school time for students everywhere. However, going back to school as a college student with diabetes poses unique challenges and …

Diabetes Drug, Farxiga Shows Promise in Patients With Heart Failure

AstraZeneca announced this week positive results from a landmark trial which showed that its diabetes drug, Farxiga reduced cardiovascular instances, …

Glenmark to Sell Combination Therapy for Adults With Type 2 Diabetes in India

Glenmark Pharmaceuticals Ltd. announced it has received regulatory approval to market a combination of a novel drug, Remogliflozinc, and Metformin …

Drawbridge Health Gets FDA Clearance for its A1C Test System

Drawbridge Health today announced it received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C …

Medtronic Gets OK to Study New Extended Wear Infusion Sets for Insulin Pumps

Medtronic has received investigational approval from the U.S. Food and Drug Administration (FDA) to proceed with a pivotal trial for a new extended …